Dosage & Administration Drug label Prior authorization Financial assistance

Remicade

(infliximab)

infliximab 100 MG Injection [Remicade]

Dosage & administration

* Prior to treatment, ensure appropriate personnel and medication are available to treat reactions (e.g., hypersensitivity) that occur during infusion and shortly after infusion
* REMICADE is administered by intravenous infusion for at least 2 hours with an in-line filter
* Crohn's Disease: 5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks. Some adult patients who initially respond to treatment may benefit from increasing the dose to 10 mg/kg every 8 weeks if they later lose their response.
* Pediatric Crohn's Disease (≥ 6 years old): 5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks.
* Ulcerative Colitis: 5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks.
* Pediatric Ulcerative Colitis (≥ 6 years old): 5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks.
* Rheumatoid Arthritis: In conjunction with methotrexate, 3 mg/kg at 0, 2 and 6 weeks, then every 8 weeks. Some patients may benefit from increasing the dose up to 10 mg/kg every 8 weeks or treating as often as every 4 weeks.
* Ankylosing Spondylitis: 5 mg/kg at 0, 2 and 6 weeks, then every 6 weeks.
* Psoriatic Arthritis and Plaque Psoriasis: 5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks.

drug label

Remicade prescribing information

Need to report a Remicade issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Remicade Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

Coverage Authorization Appeals

Learn More

Benefits investigation

Janssen CarePath IV Benefits Investigation & Enrollment Form

Janssen CarePath Benefits Investigation & Enrollment Form - Gastroenterology

Remicade Benefit Investigation Form

Patient Authorization Form - To be Sgined by Patient if HCP Office has no BAA with Janssen

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Remicade Financial assistance options

Co-pay savings program

commercial only

Janssen CarePath IV Benefits Investigation & Enrollment Form

Janssen CarePath Benefits Investigation & Enrollment Form - Gastroenterology

Patient Authorization Form - To be Sgined by Patient if HCP Office has no BAA with Janssen

Enroll in Patients Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Johnson & Johnson Patient Assistance Foundation Eligibility Check

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Remicade Patient education

Getting started on Remicade

NOT PROVIDED BY BRANDInstructions For Use: Ulcerative Colitis

NOT PROVIDED BY BRANDInstructions For Use: Pediatric Ulcerative Colitis

NOT PROVIDED BY BRANDInstructions For Use: Crohn's Disease

NOT PROVIDED BY BRANDInstructions For Use: Pediatric Crohn's Disease

NOT PROVIDED BY BRANDInstructions For Use: Plaque Psoriasis

NOT PROVIDED BY BRANDInstructions For Use: Psoriatic Arthritis

NOT PROVIDED BY BRANDInstructions For Use: Rheumatoid Arthritis

NOT PROVIDED BY BRANDInstructions For Use: Ankylosing Spondylitis